Fayez Sarofim & Co Portfolio holdings
AUM
$41.7B
1-Year Return
15.12%
This Quarter Return
+5.93%
1 Year Return
+15.12%
3 Year Return
+67.65%
5 Year Return
+130.07%
10 Year Return
+262.45%
AUM
$28.6B
AUM Growth
+$1.5B
(+5.6%)
Cap. Flow
+$281M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
43.01%
Holding
291
New
10
Increased
102
Reduced
100
Closed
10
Top Buys
| 1 |
Microsoft
MSFT
|
$73.4M |
| 2 |
AstraZeneca
AZN
|
$70M |
| 3 |
Apple
AAPL
|
$50.3M |
| 4 |
Amazon
AMZN
|
$45.8M |
| 5 |
Philip Morris
PM
|
$39.2M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$54M |
| 2 |
Meta Platforms (Facebook)
META
|
$48.4M |
| 3 |
Procter & Gamble
PG
|
$33.2M |
| 4 |
American Express
AXP
|
$32.8M |
| 5 |
T Rowe Price
TROW
|
$31M |
Sector Composition
| 1 | Technology | 23.05% |
| 2 | Consumer Staples | 18.27% |
| 3 | Financials | 17.61% |
| 4 | Energy | 12.56% |
| 5 | Healthcare | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Schlumberger
SLB
$53.7B
| $2.97M | 0.01% |
60,423
-143
| -0.2% | -$7.02K |
|
127
Ovintiv
OVV
$10.9B
| $2.95M | 0.01% |
81,733
| – | – |
|
128
Ferrari
RACE
$88.2B
| $2.95M | 0.01% |
10,870
+2,300
| +27% | +$623K |
|
|
RETA
129
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.76M | 0.01% |
30,329
| – | – |
|
130
British American Tobacco
BTI
$121B
| $2.71M | 0.01% |
77,250
| – | – |
|
131
Rockwell Automation
ROK
$38.4B
| $2.54M | 0.01% |
8,648
+4,819
| +126% | +$1.41M |
|
132
Emerson Electric
EMR
$74.9B
| $2.46M | 0.01% |
28,282
+120
| +0.4% | +$10.5K |
|
133
Ralph Lauren
RL
$19.4B
| $2.44M | 0.01% |
20,900
| – | – |
|
134
Freeport-McMoran
FCX
$66.1B
| $2.42M | 0.01% |
59,069
+24,359
| +70% | +$997K |
|
135
International Flavors & Fragrances
IFF
$16.8B
| $2.36M | 0.01% |
25,638
+5,669
| +28% | +$521K |
|
136
Fox Class A
FOXA
$27.1B
| $2.33M | 0.01% |
68,391
-267
| -0.4% | -$9.09K |
|
137
Norfolk Southern
NSC
$62.8B
| $2.26M | 0.01% |
10,644
| – | – |
|
138
IBM
IBM
$230B
| $2.23M | 0.01% |
17,003
-1,046
| -6% | -$137K |
|
139
Crown Castle
CCI
$41.6B
| $2.22M | 0.01% |
16,619
-1,038
| -6% | -$139K |
|
140
Regeneron Pharmaceuticals
REGN
$60.1B
| $2.2M | 0.01% |
2,675
+25
| +0.9% | +$20.5K |
|
141
Danaher
DHR
$143B
| $2.14M | 0.01% |
9,589
+187
| +2% | +$41.8K |
|
142
Thermo Fisher Scientific
TMO
$185B
| $2.12M | 0.01% |
3,681
-37
| -1% | -$21.3K |
|
143
Paychex
PAYX
$49.4B
| $2.11M | 0.01% |
18,429
-92
| -0.5% | -$10.5K |
|
144
CSX Corp
CSX
$60.9B
| $2.07M | 0.01% |
69,000
-1,404
| -2% | -$42K |
|
145
Biogen
BIIB
$20.5B
| $2.06M | 0.01% |
7,413
| – | – |
|
146
TSMC
TSM
$1.22T
| $2.06M | 0.01% |
22,101
+11,519
| +109% | +$1.07M |
|
147
Icon
ICLR
$13.7B
| $2.02M | 0.01% |
9,440
+5,200
| +123% | +$1.11M |
|
148
Cisco
CSCO
$269B
| $1.89M | 0.01% |
36,235
-10,650
| -23% | -$557K |
|
149
United Parcel Service
UPS
$71.6B
| $1.81M | 0.01% |
9,306
-546
| -6% | -$106K |
|
150
Marsh & McLennan
MMC
$101B
| $1.8M | 0.01% |
10,815
+1
| +0% | +$167 |
|